ARQT Q1 2020 Earnings — Arcutis Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ARQTArcutis Biotherapeutics, Inc.

$3B

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$65,000

Operating Income

-$29M

Net Income

-$28M

EPS (Diluted)

$-1.15

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$21M

Free Cash Flow

-$21M

Stock-Based Comp.

$990,000

Balance Sheet

Total Assets

$254M

Total Liabilities

$13M

Stockholders' Equity

$242M

Cash & Equivalents

$191M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$65,000	$0	—
Operating Income	-$29M	-$7M	-312.1%
Net Income	-$28M	-$7M	-320.7%